Long-term safety bucket trial with NVDX3, an osteogenic implant of human allogenic origin

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511661-11-01

Acronym

NVDX3-CLN0X

Enrollment

Registered

2024-07-10

Start date

2024-08-22

Completion date

Unknown

Last updated

2025-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal Radius fracture, Low grade degenerative lumbar spondylolisthesis by interbody spine fusion

Brief summary

Description of all SAEs, NVDX3 related AEs and AE of special interest from screening till 120 months post- core study.

Interventions

DRUGNVDX3

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Description of all SAEs, NVDX3 related AEs and AE of special interest from screening till 120 months post- core study.	—

Countries

Luxembourg

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026